Evidence map›Paper›PMID 34104388›Full record

ArticleJournal of tissue engineering

Emerging biogenesis technologies of extracellular vesicles for tissue regenerative therapeutics.

Jung-Hwan Lee, Ji-Young Yoon, Jun Hee Lee, Hae-Hyoung Lee, Jonathan C Knowles, Hae-Won Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Methods of the Large-Scale Production of Extracellular Vesicles.International journal of molecular sciences · 2022
    Review
  11. Article
  12. New paradigms in regenerative engineering: Emerging role of extracellular vesicles paired with instructive biomaterials.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2022
    Article
  13. Exosomes based advancements for application in medical aesthetics.Frontiers in bioengineering and biotechnology · 2022
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jung-Hwan LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.ORCID https://orcid.org/0000-0001-8678-5459
Ji-Young YoonInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.
Jun Hee LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.
Hae-Hyoung LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.
Jonathan C KnowlesUCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.ORCID https://orcid.org/0000-0003-3917-3446
Hae-Won KimInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Chungcheongnam-do, Cheonan, Republic of Korea.ORCID https://orcid.org/0000-0001-6400-6100
Dankook University · KRThe Royal Free Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs), including exosomes, carry the genetic packages of RNA, DNA, and proteins and are heavily involved in cell-cell communications and intracellular signalings. Therefore, EVs are spotlighted as therapeutic mediators for the treatment of injured and dysfunctional tissues as well as biomarkers for the detection of disease status and progress. Several key issues in EVs, including payload content and bioactivity, targeting and bio-imaging ability, and mass-production, need to be improved to enable effective therapeutics and clinical translation. For this, significant efforts have been made recently, including genetic modification, biomolecular and chemical treatment, application of physical/mechanical cues, and 3D cultures. Here we communicate those recent technological advances made mainly in the biogenesis process of EVs or at post-collection stages, which ultimately aimed to improve the therapeutic efficacy in tissue healing and disease curing and the possibility of clinical translation. This communication will help tissue engineers and biomaterial scientists design and produce EVs optimally for tissue regenerative therapeutics.

Indexed as

biogenesis technologiesExtracellular vesiclestherapeuticstissue regeneration

Identifiers

PMID34104388
PMCPMC8155774
OpenAlexW3164899660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.